Crospon logo

Home
About Us
Product Brochures
EndoFLIP® Technology

Clinical Applications

- Upper GI Surgery

- Bariatric Surgery

- Upper GI Imaging

- Cardiology

- Therapeutic Endoscopy

- Colorectal Imaging

Distributors
Newsroom
Events
Contact Us



 

 

First Gastric Imbrication procedures conducted with EndoFLIP

Reversible weight loss surgery to become procedure of choice

Thursday 13th May 2010

Crospon, an Irish medical device developer has today announced that its EndoFLIP® system has been used for the first time to assist in the sizing of a gastric sleeve in the newly emerging weight loss surgery technique known as gastric imbrication. Unique as a weight loss procedure, gastric imbrication is a reversible procedure with no device required to be implanted and no stomach tissue removed. With over 200,000 people engaging in surgical weight loss procedures annually in the United States the appeal and potential for such a procedure is significant.


Crospon participated as part of a randomized control trial currently underway with principal
investigators Mahendra Narwaria MS, FICS (Asian Institute of Gasroenterology Surgery,
Ahmedabad, India), Daniel R. Cottam M.D. (Surgical Weight Loss Centre of Utah), and Sunil
Sharma, M.D (University of Florida), to compare weight loss outcomes of gastric imbrication
versus sleeve gastrectomy.


Commenting, Dr. Daniel Cottam said “The EndoFLIP® device has the ability to change the
way we do bariatric surgery all over the world. There has been nothing as revolutionary as this
device since the lap band. I believe in five years we won’t know how we ever did bariatric
surgery without it”.


In the case of sleeve gastrectomy a significant portion of the stomach is surgically removed
during the weight loss procedure, whereas with the gastric imbrication procedure no stomach
tissue is removed. The Cottam technique represents an enhancement to the gastric imbrication
procedure which entails the placing of an EndoFLIP® catheter along the lesser curve of the
stomach during the procedure.


This permits the surgeon to precisely stitch the stomach to give a desired sleeve diameter. For
example, in the case of a bariatric revision procedure, it may be desirable to create a 20mm
diameter sleeve where the objective might be weight loss maintenance, whereas in the case of
a primary bariatric procedure, a 13mm diameter sleeve could be created to promote weight
loss.


Commenting on the new Cottam technique, John O’Dea, CEO, Crospon, said, “We believe
that this is a very innovative use for the EndoFLIP® technology, and that it fills an important
need for the gastric imbrication procedure, namely providing visual feedback to the surgeon as
to the size of sleeve being created”.

The Hospital Angeles, in Tijuana, Mexico under the control of Dr. Juan Antonio Lopez Corvala
and his team will be conducting training on the Gastric Imbrication surgical technique in June
using the Crospon EndoFLIP® to create the sleeve during the procedure. Larry Fulton V.P. of Sales, Crospon, commented, “This is truly breakthrough technology to allow the surgeon to create a “custom sleeve” to avoid post-operative complications. It is a perfect marriage of a new procedure and a new technology to benefit patients and to give more consistent surgical outcomes.”

Find out more about Gastric Imbrication

 

 
Newsroom Links
News Headlines
Upcoming Events
         
EndoFLIP logo   Crospon Inc. 701 Palomar Airport Rd, Carlsbad, CA 92011, USA. Phone: 1-855-CROSPON
Crospon Ireland. Galway Business Park, Dangan, Galway, Ireland Phone: +353-91-519880